gptkbp:instanceOf
|
gptkb:company
|
gptkbp:acquiredBy
|
gptkb:Alere
gptkb:St._Jude_Medical
|
gptkbp:acquisitionYear
|
2017
|
gptkbp:CEO
|
gptkb:Robert_B._Ford
|
gptkbp:countryOfOrigin
|
gptkb:United_States
|
gptkbp:divested
|
gptkb:Hospira
2015
|
gptkbp:dividendPaying
|
yes
|
gptkbp:employeeCount2023
|
~115,000
|
gptkbp:Fortune500Rank
|
yes
|
gptkbp:foundedBy
|
gptkb:Wallace_Calvin_Abbott
|
gptkbp:foundedYear
|
1888
|
gptkbp:fullName
|
gptkb:Abbott_Laboratories
|
gptkbp:headquartersLocation
|
gptkb:Abbott_Park,_Illinois,_United_States
|
https://www.w3.org/2000/01/rdf-schema#label
|
Abbott
|
gptkbp:industry
|
healthcare
nutrition
medical devices
diagnostics
branded generic pharmaceuticals
|
gptkbp:ISIN
|
US0028241000
|
gptkbp:logo
|
Abbott logo.svg
|
gptkbp:marketCap
|
~$180 billion
|
gptkbp:NAICS
|
325412
|
gptkbp:netIncome
|
$5.7 billion
|
gptkbp:notableEvent
|
2020
COVID-19 test development
|
gptkbp:notableProduct
|
gptkb:BinaxNOW
gptkb:FreeStyle_Libre
gptkb:Pedialyte
gptkb:Similac
Ensure
|
gptkbp:numberOfEmployees
|
~115,000
|
gptkbp:parentCompany
|
none
|
gptkbp:revenue
|
$40.1 billion
|
gptkbp:servesArea
|
worldwide
|
gptkbp:SIC
|
2834
|
gptkbp:spinOff
|
gptkb:AbbVie
2013
|
gptkbp:stockExchange
|
gptkb:NYSE
|
gptkbp:stockSymbol
|
gptkb:ABT
|
gptkbp:subsidiary
|
gptkb:Abbott_Diagnostics
gptkb:Abbott_Molecular
gptkb:Abbott_Nutrition
gptkb:Abbott_Point_of_Care
|
gptkbp:type
|
gptkb:public_company
|
gptkbp:website
|
https://www.abbott.com/
|
gptkbp:bfsParent
|
gptkb:Tokyo_Marathon
gptkb:Saladin_Ahmed
gptkb:Glooko_Inc.
|
gptkbp:bfsLayer
|
5
|